Thursday, May 26, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Scientists identify a new switch for controlling motor proteins

by Medical Finance
in News
Scientists identify a new switch for controlling motor proteins
9
SHARES
102
VIEWS
Share on FacebookShare on Twitter

Inside neurons, motor proteins haul precious cargo, moving essential goods along thread-like roadways called microtubule tracks.

This miniature highway system is vital for keeping neurons healthy: When traffic is flowing well, critical materials are able to reach distant areas of the cells where they’re needed. When the system breaks down, it can impede cellular function and lead to cell death.

Now, scientists have identified a new tool for traffic control. In a study published in December 2021 in the journal Development, researchers describe how an enzyme called GSK3β can act as a stop switch for a type of motor protein called kinesin 1.

Our publication details how GSK3β attaches a molecular tag to kinesin 1 motors, which causes the motors to stop without detaching from microtubule tracks. We are super excited, since now we know how to control the ‘engine’ while it is moving on a track.”


Shermali Gunawardena, Senior Author, PhD, Associate Professor, Biological Sciences, University at Buffalo College of Arts and Sciences

“Transport of cargoes by motors is a tightly coordinated process, and yet the molecular mechanisms that control these ‘engines’ along the microtubule tracks remain largely unknown,” says the study’s first author, Rupkatha Banerjee, PhD, a postdoctoral research associate at Scripps Research in Florida who completed her doctorate in biological sciences at UB.

“Our work provides an in-depth understanding of how the enzyme GSK3β acts as a key regulator of the kinesin 1 motor,” Banerjee adds. “Specifically, we have identified a precise site on kinesin 1 that is modified by GSK3β. Using molecular biology, in vitro analysis and fly genetics, coupled with in vivo imaging techniques, we were able to tease out the mechanistic details by which disruption of this particular site impacts motor movement and motor attachment to cargoes or microtubule tracks in a whole organism.”

The findings -; based on laboratory experiments, including some in the neurons of fruit fly larvae -; could open the door for future research on pausing motors as a mechanism for treating diseases.

Gunawardena highlights cancer as one potential example: “In cancer, cells are rapidly dividing, and motors are involved in this. So if you can stop the motors, you can impact this continuous division of cells,” she says.

From a different angle, she notes that, “in some neurodegenerative diseases, you see blockages of cargo within neurons because things are getting stuck on the road. If we can control the motors and stop them, maybe we can help to clear the track and get rid of these blockages. In parts of California, at rush hour, you have traffic lights that only let so many cars in at a certain time to prevent the highway from getting too full, which would slow down traffic and cause traffic blocks. Perhaps we can also apply this concept in neurons, too, if we can control motors by turning them on or off.”

Co-authors of the study also include Piyali Chakraborty, a MS graduate of UB’s neuroscience program, and Michael C. Yu, PhD, associate professor of biological sciences at UB.

In addition to detailing how GSK3β can stop kinesin 1 motors, the research explored other aspects of the enzyme’s interaction with the motors, with results underscoring the idea that GSK3β plays an important role in fine-tuning kinesin 1 motor movement within neurons inside a living organism.

“This publication emphasizes fine-tuning of motor function as a potential approach for restoring transport defects that contribute to neurodegeneration and cancer,” Banerjee says.

The research was supported by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health; the John R. Oishei Foundation; and the Mark Diamond Research Fund at UB.

Source:

Journal reference:

Banerjee, R., et al. (2021) A stop or go switch: glycogen synthase kinase 3β phosphorylation of the kinesin 1 motor domain at Ser314 halts motility without detaching from microtubules. Development. doi.org/10.1242/dev.199866

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

Study illuminates why cowpea mosaic virus is exceptionally effective against cancer

by Medical Finance
May 26, 2022
0

A plant virus that infects legumes, called cowpea mosaic virus, has a special power that you may not have known...

Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

Novel plug-and-play multi-organ chip can be customized to the patient

by Medical Finance
May 26, 2022
0

Engineered tissues have become a critical component for modeling diseases and testing the efficacy and safety of drugs in a...

Dog brains can detect speech and show different activity patterns to many languages

New drug inhibits growth of the most aggressive meningiomas

by Medical Finance
May 26, 2022
0

When a specific non-metastatic brain tumor — a meningioma — recurs after surgery and radiation treatment, a patient is normally...

Researchers investigate how messenger substances signal inflammation during damaged cell removal

Eukaryotes emerged in a no-oxygen environment in the ocean, research suggests

by Medical Finance
May 26, 2022
0

The origin of complex cells started without oxygen, new research suggests. Since the 1960s, many experts have argued that the...

Study: Shared N417-dependent epitope on the SARS-CoV-2 Omicron, Beta and Delta-plus variants. Image Credit: NIAID

Discovery of novel antibody that targets shared epitope on SARS-CoV-2 variants

by Medical Finance
May 26, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers assessed the antibody responses elicited by severe acute respiratory...

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

by Medical Finance
May 26, 2022
0

Malvern Panalytical, a company providing advanced analysis and services solutions for the pharma drug product development, as well as services...

Next Post
Higher doses of antibiotics are needed to eliminate infection in a polymicrobial environment

Higher doses of antibiotics are needed to eliminate infection in a polymicrobial environment

Researchers investigate how messenger substances signal inflammation during damaged cell removal

Function of glycolytic enzyme depends on its cellular localization

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Pandemic 620x480
    Study clarifies sex-based burdens during the pandemic, raises awareness for menstrual equity
  • Study: “It affects every aspect of your life”: A qualitative study of the impact of delaying surgery during COVID-19. Image Credit: Photoroyalty/Shutterstock
    Patient-reported impact of having surgery delayed during the COVID-19 pandemic
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply